Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15601-15650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03396601
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
PHASE3
Active, not recruiting
150 participants
Started: Jun 25, 2019 · Completed: Dec 31, 2024
2 conditions
2 sponsors
2 locations
NCT03937219
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
PHASE3
Active, not recruiting
855 participants
Started: Jun 25, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
159 locations
NCT04860947
Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients
N/A
Active, not recruiting
200 participants
Started: Jun 25, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT03941314
A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
NA
Active, not recruiting
300 participants
Started: Jun 25, 2019 · Completed: Mar 31, 2026
1 condition
3 sponsors
3 locations
NCT04018638
Blood-Flow Restriction Exercise Following a Knee Replacement
NA
Active, not recruiting
30 participants
Started: Jun 25, 2019 · Completed: Dec 25, 2025
3 conditions
2 sponsors
1 location
NCT04071691
PET Imaging of Giant Cell and Takayasu Arteritis
N/A
Active, not recruiting
27 participants
Started: Jun 25, 2019 · Completed: Apr 30, 2025
2 conditions
5 sponsors
2 locations
NCT04007289
Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
PHASE3
Active, not recruiting
166 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03933735
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
220 participants
Started: Jun 24, 2019 · Completed: May 12, 2026
1 condition
2 sponsors
14 locations
NCT03190317
Health Information for Infected Veterans
N/A
Active, not recruiting
123 participants
Started: Jun 24, 2019 · Completed: Sep 30, 2025
1 condition
3 sponsors
8 locations
NCT03876769
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
PHASE2
Active, not recruiting
122 participants
Started: Jun 24, 2019 · Completed: Oct 19, 2027
1 condition
2 sponsors
45 locations
NCT03725007
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
PHASE1
Active, not recruiting
124 participants
Started: Jun 24, 2019 · Completed: May 31, 2027
1 condition
1 sponsor
35 locations
NCT03366155
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
PHASE2
Active, not recruiting
24 participants
Started: Jun 24, 2019 · Completed: Jan 31, 2027
5 conditions
1 sponsor
1 location
NCT03843294
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
PHASE1
Active, not recruiting
18 participants
Started: Jun 24, 2019 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT03963349
THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study
N/A
Active, not recruiting
150 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05133492
First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA)
NA
Active, not recruiting
46 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
5 locations
NCT03999021
FIGHT-RP 1 Extension Study
PHASE1
Active, not recruiting
30 participants
Started: Jun 24, 2019 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT03959098
Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation
N/A
Active, not recruiting
120 participants
Started: Jun 24, 2019 · Completed: Dec 1, 2027
3 conditions
1 sponsor
1 location
NCT03879447
Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/spondylolisthesis
N/A
Active, not recruiting
110 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2027
5 conditions
1 sponsor
1 location
NCT03873402
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
PHASE3
Active, not recruiting
437 participants
Started: Jun 21, 2019 · Completed: Aug 29, 2025
1 condition
1 sponsor
78 locations
NCT03657641
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2
Active, not recruiting
75 participants
Started: Jun 21, 2019 · Completed: Jun 21, 2026
2 conditions
2 sponsors
3 locations
NCT03812393
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
PHASE2
Active, not recruiting
27 participants
Started: Jun 21, 2019 · Completed: Dec 15, 2024
3 conditions
3 sponsors
1 location
NCT03996239
Researching the Effect of Aerobic Exercise on Cancer
NA
Active, not recruiting
38 participants
Started: Jun 20, 2019 · Completed: Jun 30, 2026
1 condition
3 sponsors
10 locations
NCT03916419
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
26 participants
Started: Jun 20, 2019 · Completed: Sep 25, 2025
4 conditions
1 sponsor
1 location
NCT04009681
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
PHASE1/PHASE2
Active, not recruiting
250 participants
Started: Jun 20, 2019 · Completed: Nov 30, 2025
1 condition
1 sponsor
24 locations
NCT03187340
Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults-2
NA
Active, not recruiting
112 participants
Started: Jun 20, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03964233
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
PHASE1
Active, not recruiting
119 participants
Started: Jun 20, 2019 · Completed: May 30, 2026
1 condition
1 sponsor
23 locations
NCT04009343
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
PHASE2/PHASE3
Active, not recruiting
182 participants
Started: Jun 19, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03853486
ATHN 9: Severe VWD Natural History Study
N/A
Active, not recruiting
108 participants
Started: Jun 18, 2019 · Completed: Jul 30, 2026
1 condition
2 sponsors
22 locations
NCT03884660
remedē System Therapy Study
N/A
Active, not recruiting
225 participants
Started: Jun 18, 2019 · Completed: Dec 30, 2030
1 condition
1 sponsor
32 locations
NCT03759938
OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial
NA
Active, not recruiting
3,648 participants
Started: Jun 18, 2019 · Completed: Oct 31, 2024
2 conditions
1 sponsor
44 locations
NCT03851068
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NA
Active, not recruiting
40 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
5 locations
NCT04126525
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
PHASE2
Active, not recruiting
53 participants
Started: Jun 18, 2019 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT03765307
Bronchial Ablation for Treatment of Asthma (BATA) Trial
NA
Active, not recruiting
160 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2028
1 condition
2 sponsors
15 locations
NCT03946527
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
PHASE2
Active, not recruiting
10 participants
Started: Jun 17, 2019 · Completed: Mar 31, 2026
2 conditions
2 sponsors
2 locations
NCT03604978
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
PHASE1/PHASE2
Active, not recruiting
38 participants
Started: Jun 17, 2019 · Completed: Nov 30, 2025
3 conditions
1 sponsor
29 locations
NCT03943875
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
PHASE4
Active, not recruiting
757 participants
Started: Jun 17, 2019 · Completed: Mar 1, 2026
3 conditions
2 sponsors
1 location
NCT03944941
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
PHASE2
Active, not recruiting
60 participants
Started: Jun 17, 2019 · Completed: Dec 1, 2028
2 conditions
2 sponsors
428 locations
NCT03728985
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NA
Active, not recruiting
102 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
44 locations
NCT03895437
Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
PHASE2
Active, not recruiting
78 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2023
1 condition
1 sponsor
23 locations
NCT03283384
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
PHASE2
Active, not recruiting
100 participants
Started: Jun 15, 2019 · Completed: Aug 31, 2027
1 condition
3 sponsors
29 locations
NCT06843031
The Role of Perfusion Index in Defining Postoperative Shivering
N/A
Active, not recruiting
80 participants
Started: Jun 15, 2019 · Completed: Jun 15, 2025
3 conditions
1 sponsor
1 location
NCT04007809
Phenotypic and Genotypic Characterization of New-onset Type I Diabetes
NA
Active, not recruiting
98 participants
Started: Jun 15, 2019 · Completed: Jun 30, 2027
1 condition
3 sponsors
1 location
NCT03735901
Enhancement of Stroke Rehabilitation With Levodopa
PHASE3
Active, not recruiting
610 participants
Started: Jun 14, 2019 · Completed: Jun 30, 2029
2 conditions
2 sponsors
24 locations
NCT04000035
Health in Work - a Measure for Increased Coping and Work Inclusion
NA
Active, not recruiting
1,383 participants
Started: Jun 14, 2019 · Completed: Jul 1, 2035
3 conditions
4 sponsors
1 location
NCT04017650
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
PHASE1/PHASE2
Active, not recruiting
38 participants
Started: Jun 14, 2019 · Completed: Dec 30, 2025
16 conditions
2 sponsors
1 location
NCT03828227
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.
PHASE3
Active, not recruiting
49 participants
Started: Jun 14, 2019 · Completed: Dec 31, 2025
3 conditions
1 sponsor
22 locations
NCT03609047
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
PHASE2
Active, not recruiting
366 participants
Started: Jun 14, 2019 · Completed: Sep 30, 2032
2 conditions
9 sponsors
73 locations
NCT04173533
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
PHASE3
Active, not recruiting
326 participants
Started: Jun 14, 2019 · Completed: Apr 30, 2025
2 conditions
1 sponsor
20 locations
NCT04764500
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
N/A
Active, not recruiting
39 participants
Started: Jun 13, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03899792
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Jun 13, 2019 · Completed: May 31, 2029
5 conditions
2 sponsors
26 locations
Previous
1
More pages
310
311
312
313
314
315
316
More pages
431
Next